A Review of Thrombopoietin Receptor Agonists and Subsequent Development of Thrombosis: Exploring a Hematologic Paradox
Gillian Graifman, Ranya Parekh, Rajesh Varma C P, Arun Nair · 2026
Read A Review of Thrombopoietin Receptor Agonists and Subsequent Development of Thrombosis: Exploring a Hematologic Paradox by Gillian Graifman, Ranya Parekh, Rajesh Varma C P, Arun Nair (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13633657.txt.
Description
Gillian Graifman, Ranya Parekh, Rajesh Varma, and Arun Nair review a blood drug puzzle in a 2026 paper. A class of drugs boosts platelet output and cuts bleeding risk. The same boost might also raise the chance of clots. The authors call this tension a hematologic paradox worth close review.
The review covers four drugs in the class and how each one works. Uses span low platelet illness, severe marrow failure, and care before surgery in liver disease. Past studies do not agree on whether clots track dose, counts, or drug type. The authors weigh several causes, from fresh platelet activity to the illness itself. Prior clots, older age, and long drug use all raise concern. They urge risk checks both at the start of care and over time. No single factor, they find, explains the clot risk alone.
Catalog record
| CREATOR | Gillian Graifman, Ranya Parekh, Rajesh Varma C P, Arun Nair |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |